OTC Stock in News; Cannabis Science Inc. (CBIS)
Cannabis Science Inc. (OTC: CBIS), a developer of pharmaceutical grade medical marijuana products, on Thursday, announced that it has teamed with Dr. Ivan Goldsmith of Trimcare in Las Vegas, Nevada.
CBIS and Dr. Goldsmith are teaming up to implement novel treatments for obesity, metabolic syndrome and hormone deficiency syndromes.
CBIS said that it is thrilled to welcome Dr. Goldsmith, who is a leading medical authority on weight management and patient self-esteem issues. He has two decades of experience and is triple board certified in Internal Medicine, Anti-Aging and Bariatrics.
Dr. Goldsmith’s Trimcare runs a weight loss program. It also focuses on cosmetic procedures. With CBIS, Trimcare will be actively involved in implementing breakthroughs from cutting edge research on the endocannabinoid system.
Dr. Goldsmith said that his mission has been to enhance wellness and life expectancy through product offerings.
CBIS shares fell sharply on Thursday. The stock ended the day 4.81% lower at $0.0890 on volume of 8.08 million.
